This review explores the involvement of NADPH oxidase-related isoforms in the pathophysiological process of myocardial remodeling development through the regulation of complex molecular pathways and provides new ideas and approaches for the treatment of heart failure. This evidence concerns the gene FMO5 and heart failure.